Webinar Date: SUD Scoop Series runs November 2024-May 2025 (see "Add to Calendar" section for a listing of all dates)
Activity Dates: 11/06/2024 - 06/30/2028
Case Overview: As many as 14% of students between age 12 and 18 have misused an opioid at least once in their lifetime. This highlights the prevalence of opioid use disorder (OUD) amongst pediatric and adolescent patients. Despite this prevalence, data regarding choice of treatment, efficacy, safety, and monitoring of pediatric or adolescent patients with OUD is scarce. This presentation will highlight pertinent data regarding pediatric and adolescent opioid use disorder, the applicability of a microinduction strategy of buprenorphine towards pediatrics and adolescents, and creating monitoring parameters for OUD patients in a pediatric academic medical center.
Moderator: Aaron Salwan, PharmD, MPH, BCPP
Case Presenters:
|
Megan Kemper, PharmD Dr. Kemper has been a clinical pharmacist working with the inpatient psychiatry team at St. Louis Children’s hospital for 5 years. In this time, she has been part of a care team treating patients with substance use disorders, including alcohol, marijuana, opioids, and other substances. Her role includes providing pharmacotherapy recommendations and patient education. In addition to her patient care roles, she is a member of the BJC Healthcare Harm Reduction Committee designed to standardize care for patients with opioid use disorder across the hospital system. |
 |
Parker Lindsey, PharmD Dr. Lindsey is a PGY-2 Pediatric Pharmacy Resident at St. Louis Children’s hospital with a primary interest in child/adolescent psychiatry. Parker’s responsibilities include acute inpatient management of pediatric and adolescent patients presenting with use of substances such as marijuana, alcohol, opioids, and various illegal substances. Parker’s care of patients involves leading weekly patient education sessions to patients admitted to St. Louis Children’s Hospital’s inpatient psychiatric unit and providing pharmacotherapy recommendations to psychiatric providers. Post residency, Parker’s goal is to practice as a clinical specialist in pediatric psychiatry. |
Case Overview: Methadone is frequently cited as being a cause of QTc prolongation in patients on chronic therapy. This session will discuss the use of methadone maintenance for the treatment of opioid use disorder in the setting of QTc prolongation. It will briefly summarize the risks and benefits of using methadone in this population and considerations for new start and continuation of therapy.
Moderator: Troy Moore, PharmD, MS, BCPP
Case Presenters:
|
Zoe Karavolis, PharmD, MPH, BCPP Dr. Karavolis is a clinical pharmacist in the Alcohol, Drug, and Addiction Treatment Program at McLean Hospital. She completed post-graduate training in psychiatry at UPMC. She works closely with patients in the inpatient detox setting as well as residential and outpatient substance use clinics. She leads the hospital's take-home naloxone program and conducts overdose response training with staff members. She serves as a subject matter expert for substance use disorders to the Mass General Brigham Health System and various other professional organizations. |
 |
Cody Thomas, PharmD Dr. Thomas is a PGY2 Psychiatric Pharmacy Resident at McLean Hospital. He completed his pharmacy school education at the University of the Incarnate Word and his PGY1 pharmacy residency at Corpus Christi Medical Center. Throughout his Substance Use Disorders rotation, he actively contributed to patient care through providing medication recommendations and counseling patients on newly started medications for alcohol use disorder, opioid use disorder, and stimulant use disorder. His clinical interests includes substance use disorders, child and adolescent psychiatry, and mood disorders. |
 |
Rebecca Trojan, PharmD Dr. Trojan is a PGY2 Psychiatric Pharmacy resident at McLean Hospital. She completed her pharmacy school education at the University of Rhode Island and her PGY1 Pharmacy residency at Lawrence + Memorial Hospital in Connecticut. She is passionate about promoting harm reduction and advocating for equitable treatment for substance use disorders. Throughout her residency training, she has collaborated with various practitioners to provide comprehensive care to patients with substance use disorders and provide education on treatment modalities.
|
You must be signed in as a member to view the SUD Scoop dates.
The SUD Scoop Series is an unaccredited member-driven initiative to facilitate dialogue among psychiatric pharmacy professionals. While presenters are encouraged to disclose any conflicts and to use the best evidence available, the presentations are not peer reviewed and attendees should accordingly verify details prior to making significant practice changes.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
